FDA Approves KYGEVVI®, the First and Only Treatment for Thymidine Kinase 2 deficiency (TK2d)

Care and Connection That Matter

Access to care, trusted guidance, and meaningful programs that support individuals and families—every step of the way.

Rocky Mountain Village

The application for this session will be completed through Rocky Mountain Village's application site. Please contact swalker@mdausa.org if you are interested in receiving the application link once it's available.

Find MDA
in your Community